.:: TuttoCongressi ::.

Hai dimenticato la password? | Registrati

E-mail

Password

Resta Collegato

Cerca per parole nell'archivio:

In archivio:

N° Relazioni: 792
N° Accessi Relaz.: 155885

II FLORENCE INT. SYMPOSIUM ON ADVANCES IN CARDIOMYOPATHIES

Palazzo Congressi (FI)
26/09/2012 - 28/09/2012

	Programma Evento
	Foto: 29
	Video: 5
	Info

Mostra tutti | Mostra contenuti EasyRec

Caforio A.
Antibody-mediated response

Caforio A.
Clinically suspected and definite myocarditis: the "WG consensus statement"

Camici P.
Pathophysiology of coronary microvascular dysfunction in primary and secondary LVH

Cappato R.
Ablation of atrial and ventricular arrhythmias in patient with cardiomyopathy

Carrier L.
Take home message

Cecchi F.
Microvascular dysfunction

Cecchi F.
Heart disease : clinical management and outcome

Cecchi F.
Defining risk and the high risk patient with cardiomyopathy: the dilemma of ICD in primary prevention

Cecchi F.
Final Remarks

Cerbai E.
Molecular targets for disease-specific treatment (RAAS, intracellular calcium metabolism, Slow Ina and other currents, prevention of microvascular ischemia and fibrosis)

Charron P.
The family as a patient: clinical, ethical, legal implications

Choudhury L.
Association of LV wall thickness and myocardial fibrosis/scar with adverse events in HCM: interaction of maximal wall thickness and late gadolinium enhancement by MRI

Coppini R.
Molecular targets for disease-specific treatment (RAAS, intracellular calcium metabolism, Slow Ina and other currents, prevention of microvascular ischemia and fibrosis)